Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference24 articles.
1. Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review;Makrilia;Metal-Based Drugs,2010
2. Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer;Gadducci;International journal of gynecological cancer: official journal of the International Gynecological Cancer Society,2008
3. Oxaliplatin immune-induced syndrome occurs with cumulative administration and rechallenge: single institution series and systematic review study;Bencardino;Clin. Colorectal Cancer,2016
4. Toxicity of oxaliplatin rechallenge in metastatic colorectal cancer;Mauri;Annals of Oncology: official journal of the European Society for Medical Oncology/ESMO,2018
5. Incidence and risk of oxaliplatin-induced hypersensitivity in patients with asymptomatic prior exposure: a prospective observational study;Sohn;J Allergy Clin Immunol Pract,2018
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Case report: A rare case of acute hemolysis in advanced rectal cancer after XELOX and nivolumab treatment: analysis of drug-dependent antibodies;Frontiers in Medicine;2023-05-25
2. Platinum drugs-related safety profile: The latest five-year analysis from FDA adverse event reporting system data;Frontiers in Oncology;2023-01-11
3. Attention and Intervention of Oncologists on Oxaliplatin-induced Adverse Reactions in Mainland China: A Cross-sectional Internet-based Survey;Current Medical Science;2022-10-17
4. Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity;Clinical Colorectal Cancer;2022-06
5. A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC);Pleura and Peritoneum;2022-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3